These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9374363)

  • 21. Drug-induced thyrotoxic periodic paralysis.
    Kane MP; Busch RS
    Ann Pharmacother; 2006 Apr; 40(4):778-81. PubMed ID: 16537816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perchlorate blocking for radioimmunodetection.
    Bradwell AR; Dykes PW; Fairweather DS
    J Nucl Med; 1983 Nov; 24(11):1081-2. PubMed ID: 6313879
    [No Abstract]   [Full Text] [Related]  

  • 23. Fetal thyroid goiter after massive iodine exposure.
    Serreau R; Polack M; Leger J; Vuillard E; Thurninger O; Chemouny S; Heid M; Guibourdenche J; Jacqz-Aigrain E; Oury JF; Luton D
    Prenat Diagn; 2004 Sep; 24(9):751-3. PubMed ID: 15386468
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid protection gone awry: iododerma following potassium iodide administration prior to metaiodobenzylguanidine scintigraphy.
    Guerrero AF; Guerrero KT; Shakir KM
    Thyroid; 2011 Jan; 21(1):93-4. PubMed ID: 21162686
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hyperthyroidism and hemodialysis].
    Martín Hernández T; Torres Cuadro A; Gijón Trigueros A; Lorenzo Carrero J
    An Med Interna; 1995 Aug; 12(8):391-2. PubMed ID: 8924530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical study on human epithelial ovarian carcinoma after radioimmunodetection with 131I-labelled polyclonal antibodies].
    Yang XY
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):346-9. PubMed ID: 1782846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of L-thyroxine and a saturated solution of potassium iodide in preventing damage to the thyroid following iodine-131-labeled antibody injection.
    Abdel-Nabi H; Waldman WJ; Hinkle GH; Miller EA; Trembath L; Olsen JO; Martin EW
    NCI Monogr; 1987; (3):63-6. PubMed ID: 3821920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The preparation and study of potassium-iodide preparations for the protection of the thyroid gland after contamination with radioactive iodine (131I)].
    Nidzović Z; Popović R; Bodiroga M; Odavić M
    Vojnosanit Pregl; 1989; 46(5):330-3. PubMed ID: 2609505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid dose estimation with potassium iodide (KI) administration in a nuclear emergency.
    Jang M; Kim HK; Choi CW; Kang CS
    Radiat Prot Dosimetry; 2008; 132(3):303-7. PubMed ID: 19054795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 123I radioiodinated antibody imaging of occult ovarian cancer.
    Epenetos AA; Shepherd J; Britton KE; Mather S; Taylor-Papadimitriou J; Granowska M; Durbin H; Nimmon CC; Hawkins LR; Malpas JS
    Cancer; 1985 Mar; 55(5):984-7. PubMed ID: 3881163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iododerma occurring during thyroid protection treatment.
    Wilkin JK; Strobel D
    Cutis; 1985 Oct; 36(4):335-7. PubMed ID: 4064756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyroid nodule disease in a previously endemic goiter area].
    Gómez de la Torre R; Enguix Armada A; García L; Otero J
    An Med Interna; 1993 Oct; 10(10):487-9. PubMed ID: 8136426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.
    Becker DV; Braverman LE; Dunn JT; Gaitan E; Gorman C; Maxon H; Schneider AB; Van Middlesworth L; Wolff J
    JAMA; 1984 Aug; 252(5):659-61. PubMed ID: 6737670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radioimmunoimaging of hepatocellular carcinoma with 131I labeled antihepatoma monoclonal antibody Fab fragment].
    Sui Y; He F; Chen Z
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):537-9. PubMed ID: 10923467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of MAb (F(Ab)2 OC 125 on the survival rate of ovarian carcinoma patients.
    Nesselhut T
    Hybridoma; 1993 Oct; 12(5):567-70. PubMed ID: 8300131
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
    Finstad CL; Lloyd KO; Federici MG; Divgi C; Venkatraman E; Barakat RR; Finn RD; Larson SM; Hoskins WJ; Humm JL
    Clin Cancer Res; 1997 Aug; 3(8):1433-42. PubMed ID: 9815829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation of F(ab')2 fragment of monoclonal antibody COC166-9 and its experimental study of radioimmunoimaging for ovarian carcinoma].
    Li X; Qian H; Feng J
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):152-5. PubMed ID: 9596889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 125I-fibrinogen: thyroid blocking with 2.5 mg potassium iodide twice daily in patients after hip surgery.
    Castronovo FP
    J Nucl Biol Med (1991); 1994 Mar; 38(1):55-60. PubMed ID: 8075176
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.